Johns Hopkins
The firm anticipates regulatory submissions or clearances for 10 additional POC tests within the next two years including for troponin, COVID/flu, and tuberculosis.
GBS Developing Organic Thin-Film Transistor Tech to Detect SARS-CoV-2 Antibodies, Monitor Glucose
Premium
GBS said it expects that later this year it will launch a multiplex assay, which it is developing with the Wyss Institute, to detect antibodies against SARS-CoV-2.
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
GBS, Johns Hopkins Partner to Accelerate Development of Saliva-Based Dx Tests
The program will support Johns Hopkins' research into saliva testing and diagnostics and will help GBS form its commercialization strategy for two saliva-based tests.
Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy
Premium
The researchers hope that donor-derived cell-free DNA testing to monitor rejection can help relieve racial disparities in heart transplant outcomes.